Gabelli Funds LLC Astrazeneca PLC Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gabelli Funds LLC holds 73,180 shares of AZN stock, worth $4.85 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

73,180

Previous 73,200 0.03%

Holding current value

$4.85 Million

Previous $5.71 Million 0.11%

% of portfolio

0.04%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $1,533 - $1,752	-20 Reduced 0.03%	73,180 $5.7 Million
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $1.07 Million - $1.29 Million	-15,997 Reduced 17.93%	73,200 $5.71 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $396,695 - $452,204	-6,500 Reduced 6.79%	89,197 $6.04 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $55,701 - $62,352	900 Added 0.95%	95,697 $6.45 Million
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $32,424 - $35,850	500 Added 0.53%	94,797 $6.42 Million
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $349,550 - $379,050	-5,000 Reduced 5.04%	94,297 $6.75 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $239,970 - $272,080	-3,800 Reduced 3.69%	99,297 $6.89 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $226,923 - $294,861	-4,186 Reduced 3.9%	103,097 $6.99 Million
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $265,100 - $678,750	-5,000 Reduced 4.45%	107,283 $6.63 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $59,260 - $71,140	-1,000 Reduced 0.88%	112,283 $7.42 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $195,020 - $234,920	-3,500 Reduced 3.0%	113,283 $7.52 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $817,430 - $965,875	-15,132 Reduced 11.47%	116,783 $6.8 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $6.86 Million - $7.5 Million	123,415 Added 1451.94%	131,915 $7.92 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $566,029 - $703,504	-11,690 Reduced 57.9%	8,500 $509,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $486,219 - $561,276	-10,310 Reduced 33.8%	20,190 $1 Million
Q4 2020 Feb 05, 2021	SELL	$48.52 - $58.02 $509,460 - $609,210	-10,500 Reduced 25.61%	30,500 $1.53 Million
Q3 2020 Nov 06, 2020	SELL	$53.07 - $61.1 $2.02 Million - $2.32 Million	-38,000 Reduced 48.1%	41,000 $2.25 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $560,300 - $719,030	-13,000 Reduced 14.13%	79,000 $4.18 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $254,760 - $302,760	-6,000 Reduced 6.12%	92,000 $4.59 Million
Q3 2019 Nov 01, 2019	SELL	$40.12 - $45.47 $1.28 Million - $1.46 Million	-32,000 Reduced 24.62%	98,000 $4.37 Million
Q2 2019 Aug 02, 2019	SELL	$37.28 - $41.68 $149,120 - $166,720	-4,000 Reduced 2.99%	130,000 $5.37 Million
Q1 2019 May 02, 2019	SELL	$35.49 - $43.02 $70,980 - $86,040	-2,000 Reduced 1.47%	134,000 $5.42 Million
Q4 2018 Jan 30, 2019	SELL	$36.86 - $41.49 $479,180 - $539,370	-13,000 Reduced 8.72%	136,000 $5.17 Million
Q3 2018 Nov 02, 2018	SELL	$34.76 - $39.72 $1.22 Million - $1.39 Million	-35,000 Reduced 19.02%	149,000 $5.9 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $345,500 - $370,500	-10,000 Reduced 5.15%	184,000 $6.46 Million
Q1 2018 May 09, 2018	SELL	$32.97 - $36.63 $164,850 - $183,150	-5,000 Reduced 2.51%	194,000 $6.78 Million
Q4 2017 Feb 02, 2018	BUY	$32.09 - $34.78 $96,270 - $104,340	3,000 Added 1.53%	199,000 $6.91 Million
Q3 2017 Nov 01, 2017	BUY	$28.96 - $34.0 $5.68 Million - $6.66 Million	196,000	196,000 $6.64 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Astrazeneca PLC Transaction History